Barriers to human papillomavirus (HPV) vaccination among young adults, aged 18–35

In the United States (US), an estimated 35,900 human papillomavirus (HPV)-related cancers are diagnosed annually. HPV vaccines are projected to eliminate ∼90% of these cancers. Routine vaccination is recommended at age 11–12 with “catch-up” vaccination through age 26 and shared clinical decision mak...

Descripción completa

Detalles Bibliográficos
Autores principales: Muthukrishnan, Meera, Loux, Travis, Shacham, Enbal, Tiro, Jasmin A., Arnold, Lauren D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502683/
https://www.ncbi.nlm.nih.gov/pubmed/36161130
http://dx.doi.org/10.1016/j.pmedr.2022.101942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502683/
https://www.ncbi.nlm.nih.gov/pubmed/36161130
http://dx.doi.org/10.1016/j.pmedr.2022.101942

Ejemplares similares